High standards in thought-leadership, innovation and technological breakthroughs were all noted when a Biocomplexity Institute of Virginia Tech entrepreneur won a distinguished honor for his research that could one day transform healthcare.

Josep Bassaganya-Riera, the director of the Nutritional Immunology and Molecular Medicine Laboratory (NIMML), a leading Laboratory at the Biocomplexity Institute of Virginia Tech, won the 2017 Innovator Award presented by the Roanoke-Blacksburg Technology Council during its 18th annual TechNite Awards Dinner April 21.

Dr. Bassaganya-Riera has led the NIMML team for 15 years.  His research team focuses on precision medicine and health, and how it can be customized to the needs of the individual patient. Bassaganya-Riera spoke about his vision for precision medicine during Virginia Tech’s most recent TEDx event.  The team’s resolve to make groundbreaking contributions to health has brought them one step closer to the next generation of human clinical trials that capture human diversity and variation, enabling smarter, faster, more accurate and precise decisions for personalized, predictive medicine.

Bassaganya-Riera is a serial entrepreneur who founded three biotech Companies, including BioTherapeutics at the Virginia Tech Corporate Research Center, and leads the NIMML at the Biocomplexity Institute of Virginia Tech. He has demonstrated a track record of successfully leveraging advanced informatics and computational modeling to accelerate the development of innovative technologies into marketable nutritionals such as health waters containing abscisic acid or punicic acid, and therapeutics for inflammatory bowel disease (IBD) such as BT-11.

“My resolve to transform healthcare is the driving force behind the success we achieve in NIMML. By focusing on a unique iterative integration of large-scale clinical record mining, informatics analyses and computer modeling. We are making tangible progress toward the personalized treatment of diseases. It is a distinct honor and a privilege to be in the company of so many influential leaders and innovators who strive for progress in their fields and dig to find the answers that improve our society as a whole,” says Dr. Bassaganya-Riera. “

Dr. Chris Barrett, the Executive Director of the Biocomplexity Institute says, “Forward-thinking innovators, such as Josep Bassaganya-Riera and his team, are the very foundation of the Biocomplexity Institute. His team works tirelessly to uncover the solutions that will lead the transformation of healthcare in the future. We couldn’t be happier to see his cutting-edge work recognized by the broader community.”

In one of its largest yearly gatherings to recognize the area’s technology community, the RBTC recognized influential leaders in business and innovation. Bassaganya-Riera was one of dozens of nominees announced for awards that include STEM education, leadership, entrepreneurship and innovation.

Published by Becky Freemal, April 27, 2017
Tags: Awards and Honors  Precision Medicine